Opus Genetics, Inc.
IRD · XNASCIK 1228627fmd_05EMM5HZNXA2J4TE41X50SNFNMManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2001 to Sep 30, 2026, 75 periods
AI-written
A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.
Loading